Market Closed -
OTC Markets
03:15:04 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
0.261
USD
|
-42.00%
|
|
-36.34%
|
+770.00%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3.131
|
3.647
|
4.015
|
34.96
|
4.909
|
0.167
|
Enterprise Value (EV)
1 |
3.802
|
3.763
|
5.171
|
38.98
|
17.6
|
1.931
|
P/E ratio
|
-1.66
x
|
-0.54
x
|
-0.94
x
|
-2.73
x
|
-0.2
x
|
-0.03
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
1,042,133,143
x
|
-
|
301,388,917
x
|
7,109,459
x
|
-
|
EV / Revenue
|
-
|
1,075,285,429
x
|
-
|
336,038,614
x
|
25,492,580
x
|
-
|
EV / EBITDA
|
-
|
-
|
-2,042,189
x
|
-6,270,502
x
|
-1,811,274
x
|
-833,268
x
|
EV / FCF
|
-
|
8,529,234
x
|
-5,820,965
x
|
-16,908,027
x
|
-10,967,150
x
|
-11,973,052
x
|
FCF Yield
|
-
|
0%
|
-0%
|
-0%
|
-0%
|
-0%
|
Price to Book
|
-1.91
x
|
-1.64
x
|
-1.6
x
|
32.3
x
|
-0.26
x
|
-0.01
x
|
Nbr of stocks (in thousands)
|
628
|
1,562
|
3,065
|
4,263
|
4,631
|
5,568
|
Reference price
2 |
4.988
|
2.335
|
1.310
|
8.200
|
1.060
|
0.0300
|
Announcement Date
|
4/1/19
|
4/1/20
|
3/25/21
|
4/5/22
|
7/14/23
|
4/16/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
0.0035
|
-
|
0.116
|
0.6905
|
-
|
EBITDA
|
-
|
-
|
-2.532
|
-6.216
|
-9.719
|
-2.317
|
EBIT
1 |
-1.316
|
-1.411
|
-2.534
|
-6.399
|
-10.59
|
-2.422
|
Operating Margin
|
-
|
-40,305.66%
|
-
|
-5,516.31%
|
-1,533.21%
|
-
|
Earnings before Tax (EBT)
1 |
-1.415
|
-3.885
|
-2.861
|
-7.923
|
-23.24
|
-11.96
|
Net income
1 |
-1.415
|
-3.885
|
-2.861
|
-7.923
|
-23.24
|
-13.33
|
Net margin
|
-
|
-111,007.49%
|
-
|
-6,830.21%
|
-3,364.95%
|
-
|
EPS
2 |
-3.000
|
-4.293
|
-1.396
|
-3.000
|
-5.292
|
-1.042
|
Free Cash Flow
|
-
|
0.4412
|
-0.8883
|
-2.305
|
-1.605
|
-0.1613
|
FCF margin
|
-
|
12,607.06%
|
-
|
-1,987.45%
|
-232.44%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/1/19
|
4/1/20
|
3/25/21
|
4/5/22
|
7/14/23
|
4/16/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
0.67
|
0.12
|
1.16
|
4.02
|
12.7
|
1.76
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-0.4566
x
|
-0.6466
x
|
-1.306
x
|
-0.7612
x
|
Free Cash Flow
|
-
|
0.44
|
-0.89
|
-2.31
|
-1.61
|
-0.16
|
ROE (net income / shareholders' equity)
|
93.1%
|
196%
|
118%
|
1,116%
|
258%
|
71.9%
|
ROA (Net income/ Total Assets)
|
-
|
-1,685%
|
-352%
|
-69.8%
|
-99.8%
|
-116%
|
Assets
1 |
-
|
0.2305
|
0.8123
|
11.35
|
23.28
|
11.47
|
Book Value Per Share
2 |
-2.620
|
-1.430
|
-0.8200
|
0.2500
|
-4.140
|
-2.540
|
Cash Flow per Share
2 |
0
|
0.0500
|
0.0200
|
0.2700
|
0.0100
|
0
|
Capex
|
-
|
0.01
|
-
|
1.93
|
1.75
|
-
|
Capex / Sales
|
-
|
224.4%
|
-
|
1,662.32%
|
253.26%
|
-
|
Announcement Date
|
4/1/19
|
4/1/20
|
3/25/21
|
4/5/22
|
7/14/23
|
4/16/24
|
|
1st Jan change
|
Capi.
|
---|
| +770.00% | 1.47M | | -14.92% | 84.68B | | +13.30% | 81.12B | | +10.92% | 29.4B | | -12.71% | 16.73B | | -3.06% | 16.36B | | -2.63% | 14.92B | | -3.97% | 11.66B | | -1.42% | 11.72B | | -31.75% | 11.77B |
Other Healthcare Facilities & Services
|